A Combination of Cytokine-Induced Killer Cells With PD-1 Blockade and ALK Inhibitor Showed Substantial Intrinsic Variability Across Non-Small Cell Lung Cancer Cell Lines.
Frontiers in oncology
View this publicationFrontiers in oncology
View this publicationJournal of the American Society of Nephrology : JASN
View this publicationComputational and structural biotechnology journal
View this publicationDie Ophthalmologie
View this publicationFrontiers in immunology
View this publicationLife (Basel, Switzerland)
View this publicationJournal of affective disorders
View this publicationTranslational psychiatry
View this publicationPsychophysiology
View this publicationInternational journal of colorectal disease
View this publication